Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
122,470,452
-
Total 13F shares
-
53,808,832
-
Share change
-
+1,381,556
-
Total reported value
-
$1,112,728,096
-
Put/Call ratio
-
215%
-
Price per share
-
$20.68
-
Number of holders
-
199
-
Value change
-
+$17,661,819
-
Number of buys
-
112
-
Number of sells
-
80
Institutional Holders of Arcus Biosciences, Inc. - Common Stock (RCUS) as of Q4 2022
As of 31 Dec 2022,
Arcus Biosciences, Inc. - Common Stock (RCUS) was held by
199 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
53,808,832 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, FMR LLC, PFM Health Sciences, LP, Octagon Capital Advisors LP, BVF INC/IL, Invus Financial Advisors, LLC, Boxer Capital, LLC, and PICTET ASSET MANAGEMENT SA.
This page lists
199
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.